How is the HAS‑BLED score calculated, and are its components based on the patient’s past medical history, current clinical status, or both?

HAS-BLED Score Calculation and Component Assessment

The HAS-BLED score components are based on BOTH past medical history AND current clinical status, with particular emphasis on modifiable risk factors that should be reassessed at every patient contact 1.

Score Components (Maximum 9 points)

The HAS-BLED acronym assigns points as follows:

• H - Hypertension (uncontrolled, systolic BP >160 mmHg): 1 point 2, 3
• A - Abnormal renal OR liver function: 1 point each (maximum 2 points) 4, 2
  • Renal: serum creatinine >2.26 mg/dL, dialysis, or transplant
  • Hepatic: bilirubin >2× upper limit normal, ALT/AST/ALP >3× upper limit normal, or cirrhosis
• S - Stroke (history of hemorrhagic or ischemic stroke): 1 point 5, 2
  • Note: Some evidence suggests hemorrhagic stroke should count as 2 points (one for stroke, one for bleeding history), though this remains debated 6
• B - Bleeding history or predisposition: 1 point 4, 7
• L - Labile INR (time in therapeutic range <60-65% in VKA-treated patients): 1 point 1, 2
• E - Elderly (age >65 years): 1 point 4, 8
• D - Drugs (antiplatelet agents, NSAIDs) OR alcohol excess (≥8 units/week): 1 or 2 points 2, 3

Historical vs. Current Assessment

Key principle: The HAS-BLED score is dynamic and must be recalculated at every patient encounter 1. Here's how each component breaks down:

Based on Medical History:

• Previous stroke (permanent historical factor)
• Previous bleeding episodes (historical but informs current predisposition)
• Age (fixed at time of assessment)
• Renal/liver disease diagnosis (though function can change)

Based on Current Status:

• Blood pressure control (modifiable - must be current measurement) 1
• Current INR stability (only applies if on VKA; requires recent INR data) 1
• Current medication use (NSAIDs, antiplatelets, alcohol - all modifiable) 1
• Current renal/liver function (can deteriorate or improve) 1

Clinical Application

A HAS-BLED score ≥3 indicates high bleeding risk and warrants more frequent clinical review, but is rarely a reason to withhold anticoagulation 1, 2. The score's primary purpose is to identify modifiable bleeding risk factors that can be addressed 1.

Critical Pitfalls:

1. The "L" component only applies to VKA-treated patients - it cannot be scored in DOAC-treated patients or those not yet anticoagulated 1

2. Bleeding risk is highly dynamic - follow-up HAS-BLED scores ("delta HAS-BLED") are more predictive than baseline scores alone 1

3. The score predicts not just bleeding but also cardiovascular events and mortality 9, though it was designed specifically for bleeding risk assessment

4. Annual bleeding rates increase progressively: approximately 1% (score 0-1), 2-4% (score 2), and up to 12.5% (score ≥5) 4, 8, 4

Reassessment Strategy

Formal reassessment must occur at every patient contact 1, focusing on:

• Current blood pressure control
• Recent INR stability (if on warfarin)
• New medications (especially NSAIDs, antiplatelets)
• Changes in renal/liver function
• Alcohol consumption patterns
• New bleeding episodes

The HAS-BLED score has demonstrated moderate predictive accuracy (C-statistic 0.61-0.72) across multiple validation studies 7, 10, 11, performing at least as well as alternative bleeding risk scores like ATRIA, ORBIT, and HEMORR2HAGES 1, 4, 10.